ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,590.55
      0.27%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gracell Biotechnologies Inc (GRCL)

      7. Gracell Biotechnologies Inc (GRCL) News

      GRCL Gracell Biotechnologies Inc

      10.25
      0.00 (0.00%)
      Apr 25 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Gracell Biotechnologies Inc GRCL NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 10.25 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      10.25 10.25
      more quote information »

      Recent News

      Date Time Source Heading
      3/04/202412:22EDGAR2Form 15-12G - Securities registration termination [Section..
      2/28/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      2/26/202417:28EDGAR2Form S-8 POS - Securities to be offered to employees in..
      2/26/202417:28EDGAR2Form POS AM - Post-Effective amendments for registration..
      2/26/202417:26EDGAR2Form POS AM - Post-Effective amendments for registration..
      2/26/202417:26EDGAR2Form S-8 POS - Securities to be offered to employees in..
      2/22/202408:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/22/202408:45GLOBEGracell Biotechnologies Acquisition Completed
      2/20/202408:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/20/202407:45GLOBEGracell Biotechnologies Announces Shareholders’ Approval of..
      2/14/202408:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/30/202406:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/29/202407:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
      1/17/202416:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/08/202416:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/08/202410:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
      12/26/202308:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/26/202306:44DJNGracell ADSs Take Flight Premarket on $1.2 Billion Takeover..
      12/26/202303:05DJNAstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
      12/26/202302:01BWAstraZeneca to acquire Gracell, furthering cell therapy..
      12/26/202302:00GLOBEGracell Biotechnologies to be acquired by AstraZeneca,..
      12/22/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/21/202307:00GLOBEGracell Biotechnologies Announces China NMPA Clearance for..
      12/18/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/11/202319:30GLOBEGracell Biotechnologies Presents Updated Clinical Data from..
      11/29/202306:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
      11/28/202314:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
      11/27/202308:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
      11/21/202306:25EDGAR2Form 144 - Report of proposed sale of securities
      11/16/202308:00GLOBEGracell Biotechnologies to Participate in Inaugural Cell..
      11/14/202306:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/13/202307:30GLOBEGracell Biotechnologies Reports Third Quarter 2023 Unaudited..
      11/08/202308:30GLOBEGracell Biotechnologies Wins Overall Immunology Solution of..
      11/02/202309:00GLOBEGracell Biotechnologies to Present Updated Results from..
      11/01/202316:00GLOBEGracell Biotechnologies to Participate in Four Upcoming..
      10/31/202309:00GLOBEGracell Biotechnologies to Present Data Highlighting..
      10/30/202308:30GLOBEGracell Biotechnologies to Report Third Quarter 2023..
      9/29/202306:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/27/202308:30GLOBEGracell Biotechnologies Reports Updated Clinical Data for..
      9/27/202306:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/26/202316:00GLOBEGracell Biotechnologies Doses First Patient in Phase 1b/2..
      9/19/202309:21GLOBEGracell Biotechnologies’ CEO Dr. William Cao Named to..
      9/14/202309:15GLOBEGracell Biotechnologies to Participate in Three Upcoming..
      9/12/202316:12EDGAR2Form F-3/A - Registration statement by foreign private..
      9/06/202308:00PRNUSGracell Biotechnologies to Present Updated Clinical Data on..
      8/24/202316:10GLOBEGracell Biotechnologies to Participate in Two Upcoming..
      8/24/202316:03EDGAR2Form F-3 - Registration statement by foreign private issuers
      8/23/202306:47EDGAR2Form 144 - Report of proposed sale of securities
      8/18/202316:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      8/14/202316:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

      Your Recent History

      NASDAQ
      GRCL
      Gracell Biotechnologies
      Delayed Upgrade Clock